Need double the efficiency, says Gates
Speaking at a special session of the international AIDS conference yesterday, Gates – whose foundation is the biggest private funder of efforts to end HIV – said the world economy was under pressure.
“There are a lot of distractions – the economic turmoil, the Syrian crisis -to keep us from achieving our goal of an AIDS-free world,” said Gates.
“Research funding has remained at the same level for the past eight or nine years… but funding will determine when we get [to an AIDS-free world],” said the Microsoft founder.
One of the biggest challenges is how to protect young Africans. In 15 years’ time, 40 percent of the world’s young people would be living in Africa – over 280 million people.
“This will be the largest generation in history entering the age where they are going to be most at risk,” said Gates.
Long-acting ARVs
The two innovations that offered the most hope to end AIDS, said Gates, are a “vaccine and long-acting drugs”.
“The greatest possibility for ending AIDS is a vaccine,” said Gates, but cautioned that even if a successful vaccine was found immediately, it would still take at least eight before it could be offered to the public.
“Besides a vaccine, the super-long acting drugs are super-interesting for prevention and treatment,” he said.
Trials of long-acting injectionable ARVs (cabotegravir and rilpivirine) given once every four to six months have shown to be as safe and effective as oral ARVs. Drug companies are also looking at long-acting ARV implants.
Praising South Africa for its progress since the previous AIDS conference in 2000, Gates said that he first visited the country in 2007 and “realised that computers alone were not going to solve the world’s problems”.
After seeing the impact of AIDS, Gates and his wife, Melinda, decided to devote most of the funds of the Bill and Melinda Gates Foundation to addressing the world’s health problems. – Health-e News.
An edited version of this story was also published on IOL
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Need double the efficiency, says Gates
by kerrycullinan, Health-e News
July 21, 2016